What is Praxis Precision Medicines, Inc.'s free cash flow?

Praxis Precision Medicines, Inc. (PRAX) reported free cash flow of -$86.21M in Q1 2026.

How has Praxis Precision Medicines, Inc.'s free cash flow changed year-over-year?

Praxis Precision Medicines, Inc.'s free cash flow decreased by 62.6% year-over-year, from -$53.01M to -$86.21M.

What is the long-term trend for Praxis Precision Medicines, Inc.'s free cash flow?

Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s free cash flow has grown at a 18.7% compound annual growth rate (CAGR), from -$125.6M to -$249.12M.

Praxis Precision Medicines, Inc. PRAX Free cash flow

Free cash flow at other companies

BiogenBIIB

$594.3M+167%

Jazz PharmaceuticalsJAZZ

——

Axsome TherapeuticsAXSM

——

AlkermesALKS

——

Neurocrine BiosciencesNBIX

——

TG TherapeuticsTGTX

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$105.9M-41.7%

Net income-$92.6M-33.6%

EPS (diluted)-$3.20+2.7%

Balance sheet

See full

Cash & equivalents$536.7M+223%

Total debt$1.4M+31.3%

Total equity$1.4B+221%

Total assets$1.5B+205%

Cash flow

See full

Operating cash flow-$86.2M-62.5%

CapEx$62.0K—

Valuation

See full

Market cap$7.87B+1,075%

Enterprise value$7.34B+1,309%

Profitability

See full

Operating margin-3,927.5%-1,497pp

Net margin-3,658.5%-1,388pp

FCF margin-3,067.4%-1,030pp

Returns & leverage

See full

Return on equity-35.3%-10.9pp

Debt / equity0×0.0×

Current ratio15.9×+7.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

−$86.2Mnet cash from operating−$62.0Kcapital expenditures=-$86.21M

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s free cash flow?: Praxis Precision Medicines, Inc. (PRAX) reported free cash flow of -$86.21M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s free cash flow changed year-over-year?: Praxis Precision Medicines, Inc.'s free cash flow decreased by 62.6% year-over-year, from -$53.01M to -$86.21M.
What is the long-term trend for Praxis Precision Medicines, Inc.'s free cash flow?: Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s free cash flow has grown at a 18.7% compound annual growth rate (CAGR), from -$125.6M to -$249.12M.